Form 4: Omega Healthcare Investors Director Receives Stock Grant

Omega Healthcare Investors, Inc. reports a restricted stock grant to Director Kevin J. Jacobs as part of his compensation.

Summary

• Director Kevin J. Jacobs was granted 6,125 shares of common stock on June 5, 2026, as part of his director compensation.
• The stock grant has a value of $43.67 per share.
• These shares are subject to vesting and will convert to common stock on a one-for-one basis.
• The shares will vest on the date of the Company's 2027 Annual Meeting of Shareholders, approximately one year from the grant date.
• Following the transaction, Kevin J. Jacobs beneficially owns 46,935 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard director compensation event rather than a significant strategic or financial development.

Positives

• Director compensation is being provided in the form of stock, aligning director interests with shareholders.
• The grant is a standard component of director compensation, indicating continued engagement.

Risks

• The value of the restricted stock grant is subject to market fluctuations until it vests.
• Vesting is tied to the company's annual meeting, introducing a time-based risk for the director if they were to depart before that date.

Future Outlook

The restricted stock grant will vest on the date of the Company's 2027 Annual Meeting of Shareholders, approximately one year from the grant date, and will convert to common stock on a one-for-one basis.

Industry Context

StockSavvy.ai notes that the use of restricted stock grants for director compensation is a common practice in the healthcare REIT industry, aiming to align executive and director incentives with long-term shareholder value.

Related Party Transactions

• The restricted stock grant to Director Kevin J. Jacobs is a related party transaction as it involves compensation to a director.

Stakeholder Impact

• Shareholders: The grant aligns director interests with shareholders by providing equity-based compensation, but also dilutes ownership slightly.
• Employees: No direct impact on employees is indicated.
• Creditors: No direct impact on creditors is indicated.
• Suppliers: No direct impact on suppliers is indicated.
• Customers: No direct impact on customers is indicated.

Next Steps

• Vesting of the restricted stock grant on the date of the Company's 2027 Annual Meeting of Shareholders.

Key Dates

Keywords

Form 4, SEC Filing, Director Compensation, Restricted Stock Grant, Omega Healthcare Investors, OHI, Beneficial Ownership, Securities Exchange Act